Aarti Pharmalabs Limited (AARTIPHARM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aarti Pharmalabs Limited (NSE: AARTIPHARM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹820.00, market capitalisation ₹7,439 Cr, P/E 34.6, ROE 8.59%.
Get the AI verdict on AARTIPHARM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
AARTIPHARM price and valuation
- Share price
- ₹820.00
- Market cap
- ₹7,439 Cr
- P/E ratio
- 34.6
- P/B ratio
- 3.5
- EPS
- ₹23.51
- Book value per share
- ₹234.00
- Dividend yield
- 0.43%
AARTIPHARM profitability and growth
- ROE
- 8.59%
- ROCE
- 10.7%
- Debt to equity
- 0.37
- Revenue growth (3 yr)
- -2%
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- -3%
- Profit growth (5 yr)
- -
AARTIPHARM 52-week range
- 52-week high
- ₹932.60
- 52-week low
- ₹585.00
- Face value
- ₹5.00
AARTIPHARM shareholding pattern
- Promoters
- 42.86%
- FIIs
- 8.17%
- DIIs
- 7.22%
- Public
- 41.74%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.